The ESHRE COVID-19 Working GroupVermeulen, NathalieAta, BarisGianaroli, LucaLundin, KerstiMocanu, EdgarRautakallio-Hokkanen, SatuTapanainen, Juha S.Veiga, Anna2021-07-052021-07-052020-01-01https://hdl.handle.net/2445/178782Study question: How did coronavirus disease 2019 (COVID-19) impact on medically assisted reproduction (MAR) services in Europe during the COVID-19 pandemic (March to May 2020)? Summary answer: MAR services, and hence treatments for infertile couples, were stopped in most European countries for a mean of 7 weeks. Main results and the role of chance: By aligning the data for each country with respective epidemiological data, we show a large variation in the time and the phase in the epidemic in the curve when MAR/ART treatments were suspended and restarted. Similarly, the duration of interruption varied. Fertility preservation treatments and patient supportive care for patients remained available during the pandemic.8 p.application/pdfengcc by-nc (c) The ESHRE COVID-19 Working Group, 2020http://creativecommons.org/licenses/by-nc/3.0/es/COVID-19Reproducció humana assistidaEuropaCOVID-19Human reproductive technologyEuropeinfo:eu-repo/semantics/article2021-07-02info:eu-repo/semantics/openAccess32821857